Blockbuster Weight-Loss Drugs & Cancer Risk: Ozempic Can Affect Pancreas Cells, Experts Weigh In On Whether That’s Worrisome

Updated February 24th, 2025

Blockbuster Weight-Loss Drugs & Cancer Risk: Ozempic Can Affect Pancreas Cells, Experts Weigh In On Whether That’s Worrisome

These concerns were initially addressed in 2013 by the U.S. Food and Drug Administration (FDA), well before Ozempic's use skyrocketed in mid-2022 as a revolutionary diet drug in Hollywood

SurvivorNetTV.
Hope. Science.
Inspiration.

WATCH NOW

AI-Powered by My Health Questions

Built by medical professionals

Want to dive deeper into this article?

Try asking any of the questions below:

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider